Autophagic regulation of p62 is critical for cancer therapy

MA Islam, MA Sooro, P Zhang - International journal of molecular …, 2018 - mdpi.com
Sequestosome1 (p62/SQSTM 1) is a multidomain protein that interacts with the autophagy
machinery as a key adaptor of target cargo. It interacts with phagophores through the LC3 …

SQSTM1/p62: a potential target for neurodegenerative disease

S Ma, IY Attarwala, XQ Xie - ACS chemical neuroscience, 2019 - ACS Publications
Neurodegenerative diseases, characterized by a progressive loss of brain function, affect
the lives of millions of individuals worldwide. The complexity of the brain poses a challenge …

Bone marrow mesenchymal stromal cells in multiple myeloma: Their role as active contributors to myeloma progression

P Maiso, P Mogollón, EM Ocio, M Garayoa - Cancers, 2021 - mdpi.com
Simple Summary Multiple myeloma is a cancer of immunoglobulin-secreting cells that
accumulate in the bone marrow. Mesenchymal stromal cells are important components of …

p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities

CT Tan, NJH Soh, HC Chang, VC Yu - The FEBS journal, 2023 - Wiley Online Library
p62/Sequestosome‐1 (SQSTM1) is a selective autophagy receptor that recruits and delivers
intracellular substrates for bulk clearance through the autophagy lysosomal pathway …

p62 as a therapeutic target for tumor

M Tao, T Liu, Q You, Z Jiang - European journal of medicinal chemistry, 2020 - Elsevier
Abstract p62/SQSTM1 (hereafter as p62) is a stress-inducible cellular protein, which
interacts with various signaling proteins to regulate a variety of cellular functions. Growing …

Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression

J Tang, Y Li, S Xia, J Li, Q Yang… - International …, 2021 - spandidos-publications.com
Abstract Sequestosome 1 (SQSTM1)/p62 is an adapter protein mainly involved in the
transportation, degradation and destruction of various proteins that cooperates with …

The interaction of the tumor suppressor FAM46C with p62 and FNDC3 proteins integrates protein and secretory homeostasis

C Fucci, M Resnati, E Riva, T Perini, E Ruggieri… - Cell reports, 2020 - cell.com
FAM46C is a non-canonical poly (A) polymerase uniquely mutated in up to 20% of multiple
myeloma (MM) patients, implying a tissue-specific tumor suppressor function. Here, we …

The emerging potential role of p62 in cancer treatment by regulating metabolism

X Zhang, M Dai, S Li, M Li, B Cheng, T Ma… - Trends in Endocrinology & …, 2023 - cell.com
Abstract p62 is an important multifunctional adaptor protein participating in autophagy and
many other activities. Many studies have revealed that p62 is highly expressed in multiple …

Multiple myeloma and bone: The fatal interaction

S Marino, GD Roodman - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Multiple myeloma (MM) is the second-most-common hematologic malignancy and the most
frequent cancer to involve bone. MM bone disease (MMBD) has devastating consequences …

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

J Teramachi, H Tenshin, M Hiasa, A Oda… - …, 2020 - pmc.ncbi.nlm.nih.gov
Along with tumor progression, the bone marrow microenvironment is skewed in multiple
myeloma (MM), which underlies the unique pathophysiology of MM and confers …